Saturday, October 9, 2021

Pharma Reviews: Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate ...

... Co's experimental antiviral drug Molnupiravir in moderate Covid-19 patients, two Indian pharmaceutical companies, Aurobindo Pharma and MSN Laboratories, ...
Read more: Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate ...